206 related articles for article (PubMed ID: 36528755)
21. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.
Jiang W; Li D; Han R; Zhang C; Jin WN; Wood K; Liu Q; Shi FD; Hao J
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6202-E6211. PubMed ID: 28696300
[TBL] [Abstract][Full Text] [Related]
23. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
Front Immunol; 2021; 12():589200. PubMed ID: 33841391
[TBL] [Abstract][Full Text] [Related]
24. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice.
Huang Y; Han F; Li J; Li Y; Gao J; Lai L; Luo P; Su M; Hu R
Immunol Lett; 2023 Aug; 260():58-67. PubMed ID: 37369312
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
[TBL] [Abstract][Full Text] [Related]
26. Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Liu G; Jiang X; Han M; Lv J; Zhuang W; Xie L; Zhang Y; Wang C; Saimaier K; Yang J; Shen J; Li N; Du C
Cell Immunol; 2022 Mar; 373():104500. PubMed ID: 35276582
[TBL] [Abstract][Full Text] [Related]
27. miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3.
Xue Y; Zhang L; Guo R; Shao X; Shi M; Yuan C; Li X; Li B
J Neuroimmunol; 2023 Jun; 379():578100. PubMed ID: 37187004
[TBL] [Abstract][Full Text] [Related]
28. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
29. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
Cho JJ; Xu Z; Parthasarathy U; Drashansky TT; Helm EY; Zuniga AN; Lorentsen KJ; Mansouri S; Cho JY; Edelmann MJ; Duong DM; Gehring T; Seeholzer T; Krappmann D; Uddin MN; Califano D; Wang RL; Jin L; Li H; Lv D; Zhou D; Zhou L; Avram D
Nat Commun; 2019 Feb; 10(1):701. PubMed ID: 30741923
[TBL] [Abstract][Full Text] [Related]
30. IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.
Kurte M; Luz-Crawford P; Vega-Letter AM; Contreras RA; Tejedor G; Elizondo-Vega R; Martinez-Viola L; Fernández-O'Ryan C; Figueroa FE; Jorgensen C; Djouad F; Carrión F
Front Immunol; 2018; 9():802. PubMed ID: 29760692
[TBL] [Abstract][Full Text] [Related]
31. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
32. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
34. miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Liu SQ; Jiang S; Li C; Zhang B; Li QJ
J Biol Chem; 2014 May; 289(18):12446-56. PubMed ID: 24644282
[TBL] [Abstract][Full Text] [Related]
35. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
36. T-cell activation RhoGTPase-activating protein plays an important role in T
Tamehiro N; Nishida K; Yanobu-Takanashi R; Goto M; Okamura T; Suzuki H
Immunol Cell Biol; 2017 Sep; 95(8):729-735. PubMed ID: 28462950
[TBL] [Abstract][Full Text] [Related]
37. Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis.
Li X; Zhao L; Han JJ; Zhang F; Liu S; Zhu L; Wang ZZ; Zhang GX; Zhang Y
Front Immunol; 2018; 9():1807. PubMed ID: 30150982
[TBL] [Abstract][Full Text] [Related]
38. Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
Morianos I; Trochoutsou AI; Papadopoulou G; Semitekolou M; Banos A; Konstantopoulos D; Manousopoulou A; Kapasa M; Wei P; Lomenick B; Belaidi E; Kalamatas T; Karageorgiou K; Doskas T; Sallusto F; Pan F; Garbis SD; Quintana FJ; Xanthou G
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12269-12280. PubMed ID: 32409602
[TBL] [Abstract][Full Text] [Related]
39. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
[TBL] [Abstract][Full Text] [Related]
40. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
